Biotype GmbH

General information
Biotype GmbH
Moritzburger Weg 67
01109 Dresden, Saxony

Contact person: Wilhelm Zörgiebel, Chief Executive Officer
Company main phone: +49 (351) 8838400
Company main fax:  +49 (351) 8838403
Year founded:1999
Source of foundation:Independent foundation
Name of foundation source:Founded by Dr. Wilhelm Zörgiebel and Dr. Jörg Gabert
Corporate description / mission:
Biotype GmbH, a German biotechnology company with over 20 years of history, has successfully positioned itself as trusted provider of solutions for molecular diagnostics in Europe. Biotype develops, manufactures, and distributes molecular in-vitro diagnostic kits for the detection and quantification of DNA and RNA based biomarkers. The assays support diagnosis and therapy in various molecular applications, such as oncology, infectious diseases, forensics, dermatology and veterinary. Biotype initially started as a biotechnology company developing molecular diagnostic tests and has grown into a full-service provider offering the complete value chain in molecular in-vitro diagnostics. The company’s in-house developed tests are multiplex PCR-based and run either on established laboratory platforms or on the proprietary Modaplex device. The Modaplex system provides a novel real-time quantification procedure through the unique combination of PCR and simultaneous capillary electrophoresis. This technology enables the examination of up to 50 RNA and DNA markers in a single sample. With little hands-on time and a simple workflow, it allows to detect all types of genetic aberrations. Biotype's contract development & manufacturing services cover all challenges from the idea up to the realization of a marketable product. One of the company’s assets is platform and biomarker flexibility, meaning molecular diagnostic assays designed and developed by Biotype are optimized to customer needs, ranging from a prototype via RUO to CE-IVD. The company's goal is to provide customers, such as laboratories, pharmaceutical, and diagnostic companies, with quality and robust molecular diagnostic tools and services.
State of ownership: Private / independent
Headquarters: Yes
  • Biotechnology - Therapeutics and Diagnostics
  • Molecular diagnostics
Primary therapeutic areas:
  • Neoplasms / cancer / oncology
  • Skin and subcutaneous tissue / dermatology
Business model:
  • Manufacturer
  • R&D
  • Research on contract basis
  • Supplier / Distributor
Customer segments:
  • Hospitals
  • Large biotech & big pharma
  • Physicians / doctors
  • Small biotech
Summary Products / Services / Technologies
Description of products:
Mentype® AMLplexQS
Mentype® DIPquant
Mentype® DIPscreen
Mentype® Chimera®
Mentype® DigitalScreen
Mentype® DigitalQuant
Mentype® MycoDerm QS
Mentype® MycoDerm Lateral Flow
Collaborations & Clients
Partnering strategy / collaborations:
We are committed to utilizing our expertise and manufacturing capacities to help fill potential gaps in order to ensure a faster & efficient market entry for your diagnostic products.